Singaporean preclinical biotech developing gamma-delta T cell therapies for cancer.
Industry: Health Care
Latest Trade: $1.49 +0.01 (+0.6%)
First Day Return: 0.0%
Return from IPO: -63.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 11/18/2022 |
Offer Price | $4.00 |
Price Range $4.00 - $5.00 | |
Offer Shares (mm) | 2.4 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/13/2023 |
Offer Price | $4.00 |
Price Range $4.00 - $5.00 | |
Offer Shares (mm) | 2.4 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
The Benchmark Company |
Axiom Capital Management |
Company Data | |
---|---|
Headquarters | Singapore |
Founded | 2018 |
Employees at IPO | 25 |
Website www.cytomed.sg |